Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Antiplatelet in Post-Ablation AF
NCT03073850Phase 4Terminated
- Sponsor
- Korea University Guro Hospital
- Start
- Feb 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Korea University Guro Hospital. Started Feb 2017; status: terminated.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03073850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073850.